Brain natriuretic peptide for treating lung and bronchial diseases - more effective at bronchodilation than urodilatin used at the same doses

摘要

A pharmaceutical compsn. contg. Brain natriuretic peptide (BNP) as the active ingredient and opt. conventional pharmaceutical diluents, carriers, fillers or auxiliaries can be used in the treatment of lung and/or bronchial diseases. USE/ADVANTAGE - BNP can be used to treat lung and/or bronchial diseases, esp. obstructive respiratory disorders, such as bronchial and cardial asthma. Suitable doses are 5 ng.-1000 micro-g/kg. esp. 10 ng-100 micro-g/kg. taken parenterally esp. by intravenous injection or by inhalation. BNP is more effective than atrial natriuretic peptide (ANP) and urodilatin when used at the same doses.